Management of myelodysplastic syndromes.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D011289:Preleukemia / Q000188:drug therapy
D000970:Antineoplastic Agents; D003561:Cytarabine